Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune ...

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease.

AbolerIS Pharma has dosed the Phase I study’s first cohort subjects with its humanised anti-CD45 receptor-like protein C ...

Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease.

Monoclonal antibody 'nirsevimab' highly effective in preventing severe RSV in infants, reducing hospitalisations and ICU ...

I am a 77-year-old female in good health. I am up to date on all vaccines, but I would like to know why after each COVID shot ...

Xilio anticipates nominating a development candidate for its PSMA program in the ATACR format in the third quarter of 2025 ...

Monoclonal antibody nirsevimab provides strong real-world protection against severe RSV in infants, suggests meta-analysis ...

Scientists have found that receiving a COVID-19 booster shot in the same arm as the initial dose triggers a faster and more effective immune response, thanks to primed macrophages in nearby lymph ...

Vaccinating pregnant women against whooping cough significantly enhances the protection of newborns in their early months, a ...

Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial ...